European Archives - Page 351 of 1078 - European Medical Journal

Targeted Therapeutics in CLL and MCL

Targeted Therapeutics in CLL and MCL. Applying Emerging BTK Inhibitor Therapy Data to Practice. This infographic was supported by educational grant from Lilly.

AIT Clinical Relevance: Patients' Benefits All Along the Treatment Journey

This infographic explores the clinical relevance of allergen immunotherapies asthma, hay fever and rhinitis, and the patient benefits observed.

Introducing the Concept of Patient Blood Management and Haemovigilance in Government Sector Hospitals of Sindh, Pakistan

Patient blood management encompasses all aspects of the transfusion decision-making process, beginning with the initial patient evaluation and continuing through clinical management.

EAACI Guidelines on Diagnosis of Food Allergy: What Is New?

An engaging session presenting the newly-revised European Academy of Allergy and Clinical Immunology guidelines on the diagnosis of food allergy, centred around the accuracy of diagnostic tests and recommendations for practice.

Steroid Toxicity in Immune Thrombocytopaenia

This article summarises the occurrence of very unusual and rare steroid-related toxicity. It is a cautionary tale of modern medicine where the treatment-related adverse events are more atrocious than the primary disease.

Immunotherapy, Targeted Therapy, and Novel Approaches to Treating Lymphoma

Lymphoma experts presented an insightful exploration of clinical trial data on immunotherapy and targeted therapeutics for diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.

Editor’s Pick: Drug-Induced Thrombocytopenic Purpura

In the present systematic review and meta-analysis, the authors analysed case reports of drug-induced thrombocytopenia/drug-induced…

EHA 2023 Abstract Highlights

Classical Hodgkin lymphoma, acute promyelocytic leukaemia, post-transplant relapse, massive transfusion, and many more essential topics in haematology were explored in several unique and insightful abstracts presented at the European Hematology Association (EHA) 2023 Congress.

Real-World Experience of Biosimilar Medicines in Oncology

In this episode, moderator George Cooper, sits down with the brilliant minds of Professor Stacey Cohen and Dr. Jeff Sharman. Together, they delve into the fascinating world of Monoclonal Antibody Biosimilars and their significant impact on the field of Oncology, with a particular focus on Lymphoma and Colorectal Cancer.

Chronic Lymphocytic Leukemia (CLL) and Beyond: Management of the Infection Burden

The overall survival of patients with chronic lymphocytic leukemia (CLL) has improved significantly over the years; however, the clinical…